Allermi
Latest round
- Series A
Last raised
- Apr 2024
Total raised
- $13M
Investors
- 4
About Allermi
Based in California, US, and founded in 2022 by CEO Shani Bocian, COO Michelle Ha, and co-founder Robert Bocian, Allermi operates as a direct-to-consumer (d2c) telehealth service provider of a personalized solution to allergy care. Allermi provides a nasal spray kit, and medication for allergy relief, and has telemedicine offerings to patients for their treatment. The company’s kit offers salinity spray, which is a moisturizing saline nasal mist used to help patients hydrate and soothe their nasal passages. In addition, the company provides super spray, which is a powered nasal spray that combines up to four active ingredients into one bottle for patients to take allergy relief. Allermi offers a questionnaire to patients for medical history and allergy symptoms and provides customized solutions to it. The company offers mobile applications for smartphone users. The company generates revenue by charging for medical consultations for USD 25 yearly.90 for shipping charges.
Who invested in Allermi
4 investors across 2 rounds
See all investors in Allermi
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Allermi
Who invested in Allermi?
Allermi has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Allermi raised?
Allermi has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Allermi last raise money?
Allermi's most recent round on record is a Series A, in Apr 2024.
What does Allermi do?
Based in California, US, and founded in 2022 by CEO Shani Bocian, COO Michelle Ha, and co-founder Robert Bocian, Allermi operates as a direct-to-consumer (d2c) telehealth service provider of a personalized solution to allergy care.
Where is Allermi headquartered?
Allermi is headquartered in San Francisco, US.
Which VCs invest in companies like Allermi?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Allermi's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Allermi? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.